Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138049242> ?p ?o ?g. }
- W2138049242 endingPage "149" @default.
- W2138049242 startingPage "142" @default.
- W2138049242 abstract "Peritendinous adhesions are serious complications after surgical repair of tendons. As an anti-adhesion material, we focused on 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer, our original biocompatible polymer, and prepared an aqueous solution of MPC-containing polymer called poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate-co-p-vinylphenylboronic acid) (PMBV), which can be formed into hydrogel properties by mixture with another aqueous polymer, poly(vinyl alcohol) (PVA). The objective of the present study was to examine the possible application of the MPC hydrogel for the reduction of peritendinous adhesions.the effects of the hydrogel on peritendinous adhesions and tendon healing were examined by means of histological and mechanical analyses in a rat Achilles tendon model and a rabbit flexor digitorum profundus tendon model. Cell migration and viability were examined with use of fibroblastic NIH3T3 cells cultured in a double chamber dish.among the concentrations examined, 2.5% and 5.0% PMBV formed hydrogel properties immediately after mixing with 2.5% PVA and maintained a honeycomb microstructure with nanometer-scaled pores for three weeks after implantation. In animal models, the hydrogel formed from 5.0% PMBV remained at the sutured site during the critical period up to three weeks and disappeared by six weeks. The MPC hydrogel reduced the peritendinous adhesions histologically and mechanically by >25% at three weeks, without impairing tendon healing as determined with mechanical analyses. In the cell culture, cell migration was reduced by the MPC hydrogel, although cell viability was unaffected, indicating physical prevention, rather than cytotoxicity, to be the anti-adhesion mechanism.the MPC hydrogel that was formed by a local injection and mixture of two aqueous solutions, 5.0% PMBV and 2.5% PVA, reduced peritendinous adhesions without impairing tendon healing. This effect may be due to its excellent biocompatibility without a foreign-body reaction and the formation of a microstructure that physically prevents passage of cells but allows cytokines and growth factors to pass for healing.this nanotechnology could potentially improve the quality of surgical repair of tendon, especially the zone-II area of the digital flexor tendon." @default.
- W2138049242 created "2016-06-24" @default.
- W2138049242 creator A5005237164 @default.
- W2138049242 creator A5012103948 @default.
- W2138049242 creator A5024984245 @default.
- W2138049242 creator A5039800251 @default.
- W2138049242 creator A5047079133 @default.
- W2138049242 creator A5051023567 @default.
- W2138049242 creator A5057867013 @default.
- W2138049242 creator A5059916251 @default.
- W2138049242 creator A5073995085 @default.
- W2138049242 creator A5075239048 @default.
- W2138049242 creator A5080710493 @default.
- W2138049242 creator A5084552219 @default.
- W2138049242 date "2011-01-01" @default.
- W2138049242 modified "2023-10-14" @default.
- W2138049242 title "Reduction of Peritendinous Adhesions by Hydrogel Containing Biocompatible Phospholipid Polymer MPC for Tendon Repair" @default.
- W2138049242 cites W109228634 @default.
- W2138049242 cites W1823248622 @default.
- W2138049242 cites W1963840922 @default.
- W2138049242 cites W1963983753 @default.
- W2138049242 cites W1964094341 @default.
- W2138049242 cites W1977795762 @default.
- W2138049242 cites W1978005832 @default.
- W2138049242 cites W1980537715 @default.
- W2138049242 cites W1982954035 @default.
- W2138049242 cites W1984961195 @default.
- W2138049242 cites W2006946354 @default.
- W2138049242 cites W2016064986 @default.
- W2138049242 cites W2018605111 @default.
- W2138049242 cites W2021477077 @default.
- W2138049242 cites W2022538069 @default.
- W2138049242 cites W2028308616 @default.
- W2138049242 cites W2039272937 @default.
- W2138049242 cites W2048266439 @default.
- W2138049242 cites W2053144791 @default.
- W2138049242 cites W2068199021 @default.
- W2138049242 cites W2070434249 @default.
- W2138049242 cites W2072280479 @default.
- W2138049242 cites W2076159792 @default.
- W2138049242 cites W2140178703 @default.
- W2138049242 cites W2143828052 @default.
- W2138049242 cites W2144935370 @default.
- W2138049242 cites W2151096164 @default.
- W2138049242 cites W2154136793 @default.
- W2138049242 cites W2157653824 @default.
- W2138049242 cites W2165593379 @default.
- W2138049242 cites W2257416638 @default.
- W2138049242 cites W2402834335 @default.
- W2138049242 cites W43561137 @default.
- W2138049242 doi "https://doi.org/10.2106/jbjs.i.01634" @default.
- W2138049242 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21248211" @default.
- W2138049242 hasPublicationYear "2011" @default.
- W2138049242 type Work @default.
- W2138049242 sameAs 2138049242 @default.
- W2138049242 citedByCount "43" @default.
- W2138049242 countsByYear W21380492422012 @default.
- W2138049242 countsByYear W21380492422013 @default.
- W2138049242 countsByYear W21380492422014 @default.
- W2138049242 countsByYear W21380492422015 @default.
- W2138049242 countsByYear W21380492422016 @default.
- W2138049242 countsByYear W21380492422017 @default.
- W2138049242 countsByYear W21380492422018 @default.
- W2138049242 countsByYear W21380492422019 @default.
- W2138049242 countsByYear W21380492422020 @default.
- W2138049242 countsByYear W21380492422021 @default.
- W2138049242 countsByYear W21380492422022 @default.
- W2138049242 countsByYear W21380492422023 @default.
- W2138049242 crossrefType "journal-article" @default.
- W2138049242 hasAuthorship W2138049242A5005237164 @default.
- W2138049242 hasAuthorship W2138049242A5012103948 @default.
- W2138049242 hasAuthorship W2138049242A5024984245 @default.
- W2138049242 hasAuthorship W2138049242A5039800251 @default.
- W2138049242 hasAuthorship W2138049242A5047079133 @default.
- W2138049242 hasAuthorship W2138049242A5051023567 @default.
- W2138049242 hasAuthorship W2138049242A5057867013 @default.
- W2138049242 hasAuthorship W2138049242A5059916251 @default.
- W2138049242 hasAuthorship W2138049242A5073995085 @default.
- W2138049242 hasAuthorship W2138049242A5075239048 @default.
- W2138049242 hasAuthorship W2138049242A5080710493 @default.
- W2138049242 hasAuthorship W2138049242A5084552219 @default.
- W2138049242 hasConcept C1318750 @default.
- W2138049242 hasConcept C132050475 @default.
- W2138049242 hasConcept C136229726 @default.
- W2138049242 hasConcept C141071460 @default.
- W2138049242 hasConcept C1491633281 @default.
- W2138049242 hasConcept C159985019 @default.
- W2138049242 hasConcept C185592680 @default.
- W2138049242 hasConcept C192562407 @default.
- W2138049242 hasConcept C2776833585 @default.
- W2138049242 hasConcept C2780105995 @default.
- W2138049242 hasConcept C2780666587 @default.
- W2138049242 hasConcept C2780984734 @default.
- W2138049242 hasConcept C44228677 @default.
- W2138049242 hasConcept C521977710 @default.
- W2138049242 hasConcept C53227056 @default.
- W2138049242 hasConcept C55493867 @default.
- W2138049242 hasConcept C71924100 @default.